Please assess the completion status of the following clinical trial:

Trial Title: Colchicine Plus Phenolic Monoterpenes to Treat COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Defined cases of COVID-19 based on laboratory and/or radiological and clinical manifestation~Exclusion Criteria:~* Age \<10, Pregnancy, Sever kidney dysfunction, Previous history of allergy to Colchicine, not willing to sign informed consent form

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard Treatment (Type: EXPERIMENTAL): Patients diagnosed with COVID-19 which receive the standard treatment national guideline
- Colchicine and Herbal Phenolic Monoterpene Fractions (Type: EXPERIMENTAL): Patients diagnosed with COVID-19 which receive the standard treatment national guideline plus Colchicine and Herbal Phenolic Monoterpene Fractions

Based on this trial design, predict the completion outcome and termination type (if applicable).